Epithalon occupies a distinctive position in the research peptide landscape as the most extensively studied peptide in the Khavinson bioregulator family — a class of short synthetic peptides developed through decades of research at the Saint Petersburg Institute of Bioregulation and Gerontology in Russia. As a tetrapeptide of just four amino acids, Epithalon is one of the smallest bioactive peptides known, yet published research spanning more than 30 years attributes to it a remarkable primary mechanism: activation of telomerase, the enzyme responsible for maintaining chromosome-protecting telomere caps that shorten with each cell division and are among the most studied biomarkers of cellular aging.
This guide provides a thorough overview of Epithalon for researchers — covering its origins in the Khavinson bioregulator program, its molecular identity, the telomerase activation mechanism, published studies in longevity and pineal gland regulation, and its relationship to other aging-related research peptides in the Apex Laboratory catalog.
What Is Epithalon? The Khavinson Bioregulator Program
Epithalon (also spelled Epitalon) is a synthetic tetrapeptide with the sequence Ala-Glu-Asp-Gly (AEDG). It was developed by Professor Vladimir Khavinson at the Saint Petersburg Institute of Bioregulation and Gerontology as a synthetic analog of Epithalamin — a peptide extract isolated from the bovine pineal gland. Khavinson’s research program, spanning from the 1980s to the present, has produced a series of short bioregulatory peptides designed to target specific tissue types, with Epithalon targeting the pineal gland and neuroendocrine axis.
Epithalon Technical Specifications
- Full Name: Epithalon / Epitalon / Epithalone (Ala-Glu-Asp-Gly)
- CAS Registry Number: 307297-39-8
- Molecular Weight: 390.35 g/mol
- Amino Acid Count: 4 residues (tetrapeptide)
- Sequence: L-Alanyl-L-glutamyl-L-aspartyl-glycine
- Classification: Khavinson bioregulatory peptide / Pineal gland bioregulator
- Physical Appearance: White to off-white lyophilized powder
- Solubility: Freely soluble in bacteriostatic water
- Stability: Excellent — extremely small tetrapeptide with robust stability profile
At just 390 g/mol, Epithalon is one of the smallest bioactive peptides used in research — smaller even than GHK-Cu (403 g/mol) and dramatically smaller than most research peptides. This minimal size contributes to its exceptional stability in both lyophilized and reconstituted forms, and also raises fundamental questions about the mechanisms through which such a small molecular structure can produce documented biological effects.
Mechanism of Action: Telomerase Activation
The primary mechanism attributed to Epithalon in published research is the activation of telomerase — the ribonucleoprotein enzyme responsible for adding TTAGGG nucleotide repeats to the ends of chromosomes (telomeres). Understanding why this matters requires a brief overview of telomere biology:
Telomeres and the Hayflick Limit
Telomeres are repetitive DNA sequences (TTAGGG in humans) capping the ends of chromosomes that protect coding DNA from degradation during cell division. Due to the “end replication problem,” telomeres shorten by approximately 50-200 base pairs with each mitotic division. When telomeres reach a critically short length, cells enter replicative senescence — a permanent cell cycle arrest known as the Hayflick limit. Telomere length is therefore one of the most studied biomarkers of cellular aging, and telomerase activation has been a major research focus in longevity biology.
How Epithalon Activates Telomerase
Published research by Khavinson and colleagues has reported that Epithalon activates telomerase through upregulation of the hTERT (human telomerase reverse transcriptase) gene — the catalytic subunit of telomerase and the rate-limiting component for telomerase activity. The proposed mechanism involves derepression of hTERT gene expression in somatic cells, which normally have minimal telomerase activity. Published data from Khavinson et al. (2003) in the Bulletin of Experimental Biology and Medicine reported increased telomerase activity and telomere elongation in human somatic cell cultures treated with Epithalon.
Pineal Gland and Melatonin Regulation
A second documented mechanism involves Epithalon’s effects on pineal gland function. As a synthetic analog of pineal-derived Epithalamin, Epithalon has been reported to stimulate melatonin production and restore circadian melatonin rhythms in aging research models. Published studies documented restoration of evening melatonin peaks in aged subjects to levels comparable to younger controls, with corresponding improvements in circadian rhythm regularity. This pineal regulatory activity is proposed as a secondary mechanism contributing to Epithalon’s longevity-related effects, since melatonin itself has documented antioxidant, immunomodulatory, and chronobiological properties relevant to aging research.
Shop Longevity Research Peptides at Apex Laboratory
Epithalon · FOXO4-DRI · SS-31 · MOTS-c · Humanin · NAD+ · Thymalin — ≥99% purity, same-day shipping.
Published Research: Key Studies
Telomere Length Studies
The most cited published data on Epithalon and telomere biology comes from Khavinson’s group, reporting activation of telomerase in human fetal fibroblast cultures and pulmonary fibroblasts treated with the peptide. The studies documented increased telomere length and extended replicative lifespan of treated cells compared to untreated controls. These findings were published across several Russian and international journals including Khavinson et al. (2003) in Neuroendocrinology Letters.
Longevity Studies in Animal Models
Several published studies from the Saint Petersburg group reported extended lifespan in animal models receiving Epithalon treatment. Studies in rodent and drosophila models documented statistically significant increases in mean and maximum lifespan compared to untreated controls. These studies also reported biomarker improvements including maintained immune function, preserved reproductive capacity, and reduced age-related pathology in treated versus control groups.
Melatonin and Circadian Rhythm Research
Published clinical investigations examined Epithalon’s effects on pineal function in elderly subjects. The studies reported restoration of evening melatonin peaks, improved circadian cortisol rhythms, and improved subjective sleep quality metrics. These findings connect Epithalon’s pineal bioregulatory origin to a practical neuroendocrine outcome.
The Broader Khavinson Peptide Family
Epithalon is part of a larger family of Khavinson bioregulatory peptides, each designed to target specific tissue types. Other members available in the Apex Laboratory catalog include Thymalin (thymus-targeting immunoregulatory peptide), Pinealon (central nervous system bioregulator), and related compounds. Together, these peptides represent a unique approach to bioregulation research based on short peptide signaling molecules, distinct from the receptor pharmacology approach used by most other research peptides.
Epithalon in the Longevity Research Landscape
Understanding where Epithalon sits relative to other aging-related research compounds helps researchers design comprehensive longevity studies:
vs FOXO4-DRI (Senolytic Peptide)
FOXO4-DRI targets senescent cells for elimination (senolysis) by disrupting the FOXO4-p53 interaction that keeps senescent cells alive. Where Epithalon aims to delay cellular senescence by maintaining telomere length, FOXO4-DRI targets cells that have already become senescent. They address different stages of the aging process and represent complementary research approaches.
vs SS-31 (Mitochondrial-Targeted Peptide)
SS-31 (Elamipretide) targets mitochondrial dysfunction — another hallmark of cellular aging, independent of telomere biology. SS-31 stabilizes cardiolipin in the inner mitochondrial membrane to restore electron transport chain efficiency. Epithalon and SS-31 target entirely different aging mechanisms (telomere attrition vs mitochondrial dysfunction) and are studied in parallel in comprehensive aging research programs.
vs NAD+ and MOTS-c
NAD+ and MOTS-c address metabolic aspects of aging — NAD+ as a direct coenzyme supplement supporting sirtuins and PARPs, MOTS-c as a mitochondrial-derived peptide that activates AMPK signaling for metabolic homeostasis. These metabolic aging compounds complement Epithalon’s telomere-focused mechanism, providing researchers with tools to investigate multiple aging hallmarks within the same experimental framework.
Storage, Handling, and Reconstitution
Lyophilized Storage
Store at -20°C. At only 390 g/mol and 4 amino acids, Epithalon is one of the most stable research peptides — tetrapeptides are highly resistant to degradation. Expect 24+ months of excellent lyophilized stability. See our Peptide Storage Guide for protocols.
Reconstitution
Dissolves instantly in bacteriostatic water. For a 10 mg vial, adding 2 mL produces 5 mg/mL (5,000 mcg/mL). Use our reconstitution calculator or follow our reconstitution protocol.
After Reconstitution
Store at 2-8°C, use within 28 days. Exceptional solution stability due to tetrapeptide simplicity. Aliquot for -20°C frozen storage.
Frequently Asked Questions
What is the difference between Epithalon and Epithalamin?
Epithalamin is a crude peptide extract from bovine pineal gland tissue containing multiple bioactive peptide components. Epithalon (Ala-Glu-Asp-Gly) is the specific synthetic tetrapeptide identified as the primary active component of Epithalamin. Epithalon is a defined, pure compound with known sequence and molecular weight; Epithalamin is a biological extract with variable composition.
What is the CAS number and molecular weight of Epithalon?
CAS: 307297-39-8. Molecular weight: 390.35 g/mol. It is a tetrapeptide with sequence Ala-Glu-Asp-Gly (AEDG), making it one of the smallest bioactive peptides in research use.
How does telomerase activation relate to aging research?
Telomere shortening is one of the nine recognized hallmarks of aging. Each cell division shortens telomeres until they reach a critical length that triggers replicative senescence (permanent growth arrest). Telomerase is the enzyme that can rebuild telomeres by adding TTAGGG repeats. Activating telomerase in somatic cells is hypothesized to delay replicative senescence, which is why telomerase activators like Epithalon are subjects of active longevity research.
Is the research on Epithalon primarily from Russian laboratories?
Yes. The majority of published Epithalon research originates from Khavinson’s group at the Saint Petersburg Institute of Bioregulation and Gerontology and affiliated Russian research institutions. While this body of work has been published in both Russian and international peer-reviewed journals, researchers should evaluate the data within this context and consider the need for independent replication by additional research groups.
Is Epithalon approved for human use?
No. Epithalon has not been approved by the FDA or any Western regulatory agency for human therapeutic use. All Epithalon sold by Apex Laboratory is intended strictly for in-vitro laboratory research and is not for human consumption.
Continue Your Research
- TB-500 (Thymosin Beta-4): Mechanism & Research Guide
- Ipamorelin Research Guide: The Selective GH Secretagogue
- Peptide Storage Guide: Temperature, Stability & Shelf Life
- How to Read a Certificate of Analysis (COA)
Research Use Disclaimer
This article is provided for educational and research reference purposes only. Epithalon and all products sold by Apex Laboratory are intended exclusively for in-vitro laboratory research use and are not for human consumption. Researchers should consult the primary published literature for complete data and evaluate Khavinson peptide research within its appropriate scientific context.
